Recognizing the significance of fluid biomarkers and their role in disease progression and therapy response is crucial for the success of clinical trials. Identifying and selecting biomarkers during the pre-clinical stages can lead to a 164% higher success rate in Phase II-III clinical trials.
Uncover a Multitude of Insights from a Single Sample. Experience DNA, RNA, and Protein Analysis for faster, more sensitive results with proven PCR technology, multiplexed for more comprehensive answers.
One instrument, One workflow, comprehensive answers
Transform time-saving: Cut analysis time from 2 Days to Just 2 Hours, allowing for faster decision-making and more efficient processes.
Combining the precision of digital PCR with the dynamic range of qPCR enables multiplex biomarker measurement at fM levels.
Replace separate instruments with one all-in-one solution. A single, multifunctional instrument reduces the need for multiple tools, streamlining workflows, reducing costs, and saving space.
Adopt a fully-integrated workflow with a simple setup and two- to three-hour assay run time.
“Our strategy is to develop an integrated platform that redefines multi-omics and sets a new standard of capability in the mid-plex translational research and clinical markets.”
CEO, Codetta BioTM
Get in touch with our team to see how the Codetta Platform can meet your multi-omics testing needs.